HCPs are still working on the balance of virtual and in-person meetings with pharma companies, but a new Accenture study finds most prefer a mix of both.

Dig­i­tal clut­ter threat­ens phar­ma-to-physi­cian re­la­tion­ships in shift to next era of com­mu­ni­ca­tions

Ed­i­tor’s Note: For more news, analy­sis and ex­clu­sive cov­er­age from the mar­ket­ing beat, sub­scribe to the End­points Mar­ket­ingRx week­ly re­port in your read­er pro­file.

Phar­ma com­pa­nies have more dig­i­tal doors to doc­tors than ever be­cause of the Covid-19 pan­dem­ic, but health­care providers think many can do bet­ter.

While 86% of HCPs rec­og­nize that phar­ma com­pa­nies are more con­sid­er­ate of their needs now, al­most two-thirds (65%) al­so say at least one phar­ma has “spammed” them with dig­i­tal con­tent in the past year. And 64% agree that the vol­ume of dig­i­tal con­tent from phar­ma com­pa­nies is too much, ac­cord­ing to the Ac­cen­ture study set for re­lease Mon­day.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.